INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
138 hedge funds and large institutions have $274M invested in Insys Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
52% less call options, than puts
Call options by funds: $3.44M | Put options by funds: $7.11M
Holders
138
Holding in Top 10
–
Calls
$3.44M
Puts
$7.11M
Top Buyers
| 1 | +$5.24M | |
| 2 | +$2.11M | |
| 3 | +$2.07M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.49M |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
+$1.1M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$7.22M | |
| 3 | -$4.51M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.29M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.9M |